Compare CRDL & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDL | BSET |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.1M | 153.2M |
| IPO Year | 2017 | 1995 |
| Metric | CRDL | BSET |
|---|---|---|
| Price | $1.49 | $14.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 29.1K |
| Earning Date | 05-13-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 5.52% |
| EPS Growth | N/A | ★ 163.06 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $456,855,000.00 |
| Revenue This Year | N/A | $4.26 |
| Revenue Next Year | N/A | $4.46 |
| P/E Ratio | ★ N/A | $111.46 |
| Revenue Growth | N/A | ★ 0.96 |
| 52 Week Low | $0.88 | $13.17 |
| 52 Week High | $1.59 | $19.75 |
| Indicator | CRDL | BSET |
|---|---|---|
| Relative Strength Index (RSI) | 69.76 | 52.98 |
| Support Level | $0.95 | $13.43 |
| Resistance Level | $1.59 | $14.69 |
| Average True Range (ATR) | 0.10 | 0.59 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 95.74 | 80.23 |
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.